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Pain therapy is a part of the oncological illnesses complex treatment. 
This therapy doesn’t solve the cause of cancer, but significantly increase 
patient’s quality of life during oncological treatment, even in the terminal stage. 
The main target of this work is to give basic information about pain treatment, 
focusing on the oncological pain, and elaborate a review of pharmacological 
groups and individual substances most used in oncological pain treatment. 
Basic pillar of the cancer pain treatment is pharmacotherapy, which goes 
out of the WHO three-grade analgesic ladder. Basic therapy is made of 
nonopioid analgesics. In case that they aren’t enough, we can add weak opioids, 
which can be replaced by strong opioids afterwards. Analgesics are usually 
used repeatedly and often in combinations. Dosage interval depends on 
pharmacological properties, dosage form and patient condition. Well controlled 
pain phases are usually interrupted by very strong, cruel pain episodes, which 
are called break-through pain.  
Very strong pain, fully or partially resistant to the effect of opioids or with 
a developed tolerance to effect of the main analgesics should be treated by 
another wide group of medicaments, called in general as co-analgesics. They 
are usually used simultaneously with the basic analgesics for pain conditions, 
which can’t be single managed by only analgesics. In the end there is 
mentioned a brief review of another possibilities of cancer pain therapy. 
 
